• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦ EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Chronic Disease

Interpersonal discrimination associated with poorer mental health, wellbeing, and substance use in young adults

byRebecca SeligaandAlex Gipsman, MD
November 8, 2021
in Chronic Disease, Pediatrics, Psychiatry, Public Health
Reading Time: 3 mins read
Children’s hospital visits for suicide ideation and attempts are increasing
Share on FacebookShare on TwitterShare on LinkedIn

1. This large study of a nationally representative sample of young adults found that over 90% had experienced some form of interpersonal discrimination including ageism, sexism, racism, discrimination based on physical appearance, or other.

2. All forms of discrimination were associated with poorer mental health, wellbeing, and substance abuse outcomes, and these associations persisted up to six years after the discrimination event.

Evidence Rating Level: 2 (Good)

Study Rundown: The negative impacts of discrimination on an individual’s health and wellbeing have been well-established by cross-sectional studies, however studies of its longitudinal effects are lacking. This study aimed to investigate the effects of interpersonal discrimination on mental health, wellbeing, and substance use in a nationally representative sample of young adults. Overall, the vast majority of young adults had experienced some form of interpersonal discrimination, including ageism, sexism, racism, discrimination based on physical appearance, and other discrimination. Regardless of the type of discrimination, all were associated with poorer mental health, wellbeing, and substance use outcomes even years after the reported event. This data highlights the need for both physical and mental health care to focus on addressing interpersonal discrimination and supporting young adults who have experienced it. This study is strengthened by its use of a large nationally representative sample and its assessment of both cross-sectional and longitudinal outcomes. Nevertheless, this study has several weaknesses including its reliance on self-reports which makes it prone to significant recall bias and misinterpretation by participants. Lastly, this study was not able to comment on institutional and structural discrimination, which likely have a significant impact on health as well.

Click to read the study in PEDIATRICS

Relevant Reading: Racial discrimination and child and adolescent health in longitudinal studies: A systematic review

RELATED REPORTS

Stool biomarkers may be effective in the evaluation of necrotizing enterocolitis in preterm infants

Artificial intelligence (AI)-powered mental health app demonstrated improved social well-being among users

In-Depth [prospective cohort]: This study gathered survey data via telephone interview from 1834 participants aged 18-28 enrolled in the Panel Study of Income Dynamics, Transition to Adulthood Supplement. Experiences of interpersonal discrimination were measured using the Everyday Discrimination Scale and categorized as racial and ethnic identity or ancestry discrimination, sex discrimination, age discrimination, physical appearance discrimination, or other. Mental health and wellbeing were assessed using mental illness diagnoses, the Kessler Psychological Distress Scale (K6) score, and the Languishing and Flourishing (L/F) score. Self-reported health was assessed using a scale, and drug use was assessed as a binary variable. Logistic regression was used to account for correlation and data were reported as relative risk (RR). Overall, 93% of study participants experienced some form of discrimination, with ageism being the most prevalent (26%), followed by physical appearance discrimination (19%), sexism (14%), and racism (13%). In both cross-sectional and longitudinal analyses, discrimination of all forms was significantly associated with a higher prevalence of languishing, psychological distress, mental illness, drug use, and poorer self-reported health. RR from discrimination of any form was highest for psychological distress (2.03 95%CI 1.7–2.4), and this association persisted up to 6 years after the discrimination exposure. There were no statistically distinguishable differences between the different types of discrimination.

Image: PD

©2021 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: discriminationmental healthsubstance use
Previous Post

Sex differences in cardiovascular outcomes of older adults after myocardial infarction

Next Post

Automatic positive airway pressure may be used as alternative therapy amongst bariatric patients with obstructive sleep apnea

RelatedReports

An incubator for preterm infants, alongside monitoring equipment and oxygen delivery components.
Gastroenterology

Stool biomarkers may be effective in the evaluation of necrotizing enterocolitis in preterm infants

October 26, 2026
A woman engages with a mental health app on her phone, while another woman provides support. The image symbolizes the connection between technology and mental well-being.
Artificial Intelligence

Artificial intelligence (AI)-powered mental health app demonstrated improved social well-being among users

October 15, 2026
An illustration depicting telemedicine services connecting two hospitals through a digital interface, emphasizing interhospital transfer and remote healthcare delivery.
Chronic Disease

Video mental health care may have clinical advantages versus phone or in-person visits

September 12, 2026
A funnel containing papers, a laboratory sample container, a physician working on a laptop, and a clock in the background, suggesting automation in medical workflows.
Artificial Intelligence

Universal Health Services acquisition of Talkspace connects virtual and inpatient behavioral care

September 9, 2026
Next Post
Adenotonsillectomy improves behavior in childhood obstructive sleep apnea (CHAT Trial)

Automatic positive airway pressure may be used as alternative therapy amongst bariatric patients with obstructive sleep apnea

Reduced HPV vaccine doses may be adequate

Risk of adverse outcomes from COVID-19 is higher for patients with cancer

Quick Take: Association of Prenatal Exposure to Air Pollution with Autism Spectrum Disorder

Intranasal oxytocin showed no benefits for pediatric autism spectrum disorder

✦ EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

NPI Lookup · Free

Look up any US clinician

Search by name or NPI number, live from the CMS NPI Registry.

  • OIG exclusion check
  • Licenses and specialties
  • No account needed
Open NPI Lookup →

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Stool biomarkers may be effective in the evaluation of necrotizing enterocolitis in preterm infants
  • Tarlatamab plus durvalumab improved survival versus durvalumab alone in extensive-stage small cell lung cancer, Amgen reports in interim phase 3 results
  • Sacituzumab tirumotecan improved overall survival versus platinum chemotherapy in company-reported final phase 3 results
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓NPI watchlist + bulk NPI verification

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.